WHO pauses hydroxychloroquine trial over safety concerns

439

The World Health Organization said that it has suspended its trial of the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business,…